Ko­re­a's Cell­tri­on in­vests $453M in­to new man­u­fac­tur­ing plant, re­search cen­ter

Less than a year af­ter blue­print­ing a $514 mil­lion bi­o­log­ics plant in Chi­na, Cell­tri­on is pour­ing an­oth­er $453 mil­lion in­to build­ing a new re­search cen­ter and man­u­fac­tur­ing fa­cil­i­ty in its home city of In­cheon, Ko­rea.

Like Sam­sung Bi­o­log­ics, which is plan­ning to con­struct a $2 bil­lion “su­per plant,” Cell­tri­on said it’s look­ing to “proac­tive­ly re­spond to the rapid­ly in­creas­ing glob­al bio­phar­ma­ceu­ti­cal de­mand, and fo­cus our ca­pa­bil­i­ties on more flex­i­ble and ef­fi­cient bio­phar­ma­ceu­ti­cal re­search in the fu­ture.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER